Market research

African Swine Fever Virus Detection Kit

Explore licenses

360iResearch introduction

African Swine Fever Virus Detection Kits: Executive Summary

African swine fever (ASF) is a highly contagious viral disease affecting domestic and wild suids. Detection kits support surveillance, outbreak confirmation, movement controls, and eradication activities, but they do not prevent infection or replace biosecurity. The most established laboratory approach is real-time PCR targeting ASF virus genetic material, complemented in some programs by antibody testing and sequencing. Because ASF can spread through animals, pork products, feed, fomites, and vectors, dependable testing must be integrated with veterinary reporting, traceability, quarantine, and validated sample handling.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Product Type

    • ELISA Kits
    • PCR Kits
    • Rapid Test Kits
    View chapter
  2. Chapter 8 Sample Type

    • Blood
    • Tissue
    • Urine
    View chapter
  3. Chapter 9 Technology

    • Loop-Mediated Isothermal Amplification
    • Next Generation Sequencing
    • Real-Time PCR
    View chapter

How Surveillance, Biosecurity, and Regulation Are Reshaping ASF Detection

The ASF detection landscape is shifting from reactive diagnosis toward risk-based, continuous surveillance. Authorities increasingly combine testing at farms, slaughterhouses, border checkpoints, and wildlife interfaces with digital traceability and compartmentalization. Demand for faster workflows is encouraging portable instruments, simplified extraction, multiplex assays, and better cold-chain alternatives, although laboratory confirmation remains essential for regulatory decisions. Harmonized validation, proficiency testing, reference materials, and transparent reporting are becoming more important as countries seek comparable results across public, private, and veterinary laboratories.

Artificial Intelligence’s Role in ASF Detection and Response

Artificial intelligence can strengthen ASF programs by prioritizing sampling locations, identifying unusual mortality patterns, integrating laboratory results with animal movements, and analyzing environmental or genomic data. Computer vision may assist with clinical screening and carcass assessment, but these applications require representative datasets and independent validation. AI should support-not replace-validated diagnostic assays, trained veterinarians, and official confirmation. Leaders should also address data governance, cybersecurity, explainability, false positives, and the operational consequences of automated alerts before deploying AI in high-consequence disease control.

Regional ASF Detection Priorities Across Six Geographies

North America emphasizes prevention, import controls, preparedness, and protection of commercial and backyard production, with surveillance shaped by extensive trade and wildlife interfaces. Latin America faces the need to strengthen early-warning networks, laboratory capacity, border controls, and producer access to affordable testing across diverse production systems. Europe combines structured veterinary surveillance with intensive wild-boar monitoring and cross-border coordination, while the Middle East requires adaptable testing networks for varied production, import, and logistics conditions. Africa remains central to ASF control because of complex domestic–wild suid interfaces and uneven diagnostic access. Asia-Pacific requires scalable surveillance across dense production networks, live-animal movements, and geographically dispersed islands and rural areas.

ASF Detection Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members benefit from coordinated regional protocols, laboratory networking, and controls tailored to dense trade and smallholder systems. BRICS cooperation can support shared research, reference materials, training, and cross-border surveillance, while national implementation remains essential. The European Union relies on coordinated animal-health rules, harmonized reporting, and collaboration between member-state laboratories; the G7 can advance preparedness, standards, and research coordination. GCC countries need surveillance aligned with import pathways, food-security objectives, and concentrated production systems. NATO is not a veterinary regulatory bloc, but its members can contribute through resilience planning, critical-infrastructure protection, and civil–military coordination where animal-disease events affect logistics or food security.

Country-Level Priorities for Reliable ASF Testing

Australia prioritizes strict biosecurity and prevention of introduction, while Brazil must integrate large-scale commercial production with wildlife and regional surveillance. Canada and the United States require strong border preparedness, producer reporting, and laboratory surge capacity. China, India, Japan, and South Korea need surveillance suited to dense, diverse production and complex animal movements. France, Germany, Italy, and Spain depend on coordinated domestic and cross-border monitoring, including wild-boar interfaces where relevant. Mexico must reinforce preparedness across trade corridors and varied production systems. Russia requires geographically broad surveillance and laboratory coordination. The United Kingdom benefits from import-risk management, rapid reporting, and preparedness for incursion response.

Actions Industry Leaders Can Take to Improve ASF Readiness

Industry leaders should establish testing plans linked to risk assessments rather than relying on ad hoc sampling. Priorities include validated assays, documented chain of custody, internal controls, trained personnel, proficiency testing, and clear escalation thresholds. Producers should map animal, feed, vehicle, personnel, and product movements; separate clean and dirty workflows; and maintain auditable visitor and mortality records. Organizations operating across borders should align procedures with competent authorities and ensure that results are securely shared. Investments in portable or automated tools should be evaluated against accuracy, throughput, maintenance, operator skill, sample logistics, and confirmatory-laboratory requirements.

Methodology for a Verified ASF Detection Kit Assessment

This executive summary uses a structured review of authoritative animal-health guidance, official surveillance and outbreak reporting, peer-reviewed diagnostic research, and publicly documented laboratory practices. Findings are organized around assay performance, specimen suitability, workflow requirements, regulatory use, surveillance design, and regional operating conditions. Evidence should be triangulated across independent sources, with attention to publication date, geographic relevance, validation status, and differences between laboratory research and field deployment. No market estimates, forecasts, market shares, or company-specific claims are used.

Conclusion: Detection Is the Foundation of Coordinated ASF Control

Effective ASF management depends on early, accurate, and traceable detection embedded in a broader response system. PCR-based confirmation remains central, while field-ready workflows, genomic tools, digital surveillance, and carefully governed AI can improve speed and targeting. The strongest programs combine validated diagnostics with biosecurity, movement controls, wildlife monitoring, producer engagement, and transparent public reporting. Industry leaders should prioritize interoperability, quality assurance, workforce capability, and rapid coordination with veterinary authorities to reduce delays between suspicion, confirmation, and action.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.African Swine Fever Virus Detection Kit Market, by Product Type
    1. 7.1Introduction
    2. 7.2ELISA Kits
    3. 7.3PCR Kits
      1. 7.3.1Conventional PCR
      2. 7.3.2Real-Time PCR
    4. 7.4Rapid Test Kits
  8. 8.African Swine Fever Virus Detection Kit Market, by Sample Type
    1. 8.1Introduction
    2. 8.2Blood
      1. 8.2.1Plasma
      2. 8.2.2Serum
    3. 8.3Tissue
    4. 8.4Urine
  9. 9.African Swine Fever Virus Detection Kit Market, by Technology
    1. 9.1Introduction
    2. 9.2Loop-Mediated Isothermal Amplification
    3. 9.3Next Generation Sequencing
    4. 9.4Real-Time PCR
      1. 9.4.1Qualitative
      2. 9.4.2Quantitative
  10. 10.African Swine Fever Virus Detection Kit Market, by End User
    1. 10.1Introduction
    2. 10.2Diagnostic Laboratories
    3. 10.3Hog Farms / Pork Producers
      1. 10.3.1Large Commercial Farms
      2. 10.3.2Small-scale Farms
    4. 10.4Research Institutes
    5. 10.5Veterinary Hospitals
  11. 11.African Swine Fever Virus Detection Kit Market, by Distribution Channel
    1. 11.1Introduction
    2. 11.2Offline
    3. 11.3Online
  12. 12.African Swine Fever Virus Detection Kit Market, by Region
    1. 12.1Introduction
    2. 12.2Asia-Pacific
    3. 12.3Europe
    4. 12.4North America
    5. 12.5Latin America
    6. 12.6Africa
    7. 12.7Middle East
  13. 13.African Swine Fever Virus Detection Kit Market, by Group
    1. 13.1Introduction
    2. 13.2NATO
    3. 13.3G7
    4. 13.4European Union
    5. 13.5BRICS
    6. 13.6ASEAN
    7. 13.7GCC
  14. 14.African Swine Fever Virus Detection Kit Market, by Country
    1. 14.1Introduction
    2. 14.2United States
    3. 14.3China
    4. 14.4Germany
    5. 14.5Japan
    6. 14.6India
    7. 14.7United Kingdom
    8. 14.8France
    9. 14.9Canada
    10. 14.10Australia
    11. 14.11Italy
    12. 14.12Brazil
    13. 14.13Mexico
    14. 14.14South Korea
    15. 14.15Russia
    16. 14.16Spain
  15. 15.Competitive Landscape
    1. 15.1Market Share Analysis, 2025
    2. 15.2Market Concentration Analysis, 2025
      1. 15.2.1Concentration Ratio (CR)
      2. 15.2.2Herfindahl Hirschman Index (HHI)
    3. 15.3Recent Developments & Impact Analysis, 2025
    4. 15.4Product Portfolio Analysis, 2025
    5. 15.5Benchmarking Analysis, 2025
  16. 16.Company Profiles
    1. 16.1Bio-Rad Laboratories, Inc.
    2. 16.2BioChek B.V.
    3. 16.3Bionote, Inc.
    4. 16.4Biosellal
    5. 16.5Eppendorf SE
    6. 16.6F. Hoffmann-La Roche Ltd.
    7. 16.7IDEXX Laboratories, Inc.
    8. 16.8INDICAL BIOSCIENCE GmbH
    9. 16.9Innovative Diagnostics SAS
    10. 16.10Krishgen Biosystems
    11. 16.11Meridian Bioscience, Inc.
    12. 16.12NZYtech, Lda
    13. 16.13Qiagen N.V.
    14. 16.14Ring Biotechnology Co., Ltd.
    15. 16.15Thermo Fisher Scientific Inc.
    16. 16.16Vetnostics
    17. 16.17Virbac S.A.
    18. 16.18Xi'an Tianlong Science and Technology Co., Ltd
  17. 17.Key Experts

Loading the sample request form…